1.10Open1.10Pre Close0 Volume2 Open Interest95.00Strike Price0.00Turnover218.24%IV41.35%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier9DDays to Expiry1.10Extrinsic Value100Contract SizeAmericanOptions Type-0.0435Delta0.0017Gamma145.55Leverage Ratio-0.2715Theta-0.0018Rho-6.33Eff Leverage0.0229Vega
Natera Stock Discussion
Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer
How Natera's New Patent Could Reshape Cancer Detection Technology
Natera Scores Critical Medicare Coverage Win for Lung Cancer Test - What This Means for Patients and Investors
Major Clinical Guidelines Update: Natera's Cancer Test Shows 20x Better Risk Detection
-Billionaire investor Stanley Druckenmiller told Bloomberg on Wednesday that selling all his Nvidia stock this year was a “big mistake.”
-Nvidia was Druckenmiller's top holding a year ago, but he sold it after the stock tripled in 2023.
-The shares are up another 174% this year, and Druckenmiller has missed much of the continuing rally.
Stanley Druckenmiller is an American billionair...
No comment yet